Sky Medical Technology
Bioelectronic wearables for circulatory conditions and recovery.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
N/A | Grant | ||
| Total Funding | 000k | ||
| GBP | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 387 % | 2342 % | 93 % | (66 %) | (10 %) | 274 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (21529 %) | (5873 %) | (267 %) | (164 %) | (772 %) | (725 %) | (221 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (19757 %) | (5593 %) | (248 %) | (140 %) | (741 %) | (687 %) | (210 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Sky Medical Technology, founded in 2006 by CEO Bernard Ross, is a UK-based medical device company that develops bioelectronic products for a variety of circulatory conditions. Ross, a serial entrepreneur with over 20 years of experience in pharmaceuticals and technology, established the company to commercialize its proprietary OnPulse™ bioelectronic technology. This technology was developed from the work of two doctors specializing in blood flow and nerve stimulation.
The company's core product is the geko™ device, a small, watch-sized wearable applied to the knee. The device operates by delivering painless electrical impulses via neuromuscular electrostimulation (NMES) to the common peroneal nerve, which activates the calf and foot muscle pumps. This process increases blood flow in the deep veins at a rate equivalent to 60% of walking, but without the patient having to move or exert energy, and with no change in heart rate or blood pressure. The geko™ device is manufactured by Firstkind, a wholly-owned subsidiary of Sky Medical.
The company serves the global healthcare market, with applications for its technology in preventing venous thromboembolism (VTE), reducing edema post-surgery, and accelerating the healing of chronic wounds like venous leg ulcers. It has received numerous regulatory approvals, including multiple FDA clearances and a UK Conformity Assessed Mark. Sky Medical also produces the Firefly device for the sports recovery market, which is used by professional athletes and teams to speed up post-training recovery. The business model appears to be B2B, selling its devices to hospitals and healthcare systems globally, with exports accounting for 95% of sales. As of April 2023, the company has raised a total of $48.8M over 16 funding rounds from investors including Deepbridge Capital, Juno Capital, and Bionow.
Keywords: bioelectronic medicine, neuromuscular electrostimulation, medical wearables, circulatory conditions, OnPulse technology, geko device, venous thromboembolism prevention, edema reduction, wound healing, sports recovery, medical devices, neuromuscular stimulation, blood flow stimulation, medtech, postoperative recovery, VTE prevention, chronic wound care, Firefly device, non-invasive treatment